SB 353-FN (2024): relative to insurance coverage for autism spectrum disorder and Down syndrome.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “SB 353-FN (2024): relative to insurance coverage for autism spectrum disorder and Down syndrome.” Granite Record, https://graniterecord.org/bill/2024/sb353. Accessed 24 Oct. 2026.
- APA
- Granite Record. (n.d.). SB 353-FN (2024): relative to insurance coverage for autism spectrum disorder and Down syndrome. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2024/sb353
- Chicago
- Granite Record. “SB 353-FN (2024): relative to insurance coverage for autism spectrum disorder and Down syndrome.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2024/sb353.
- BibTeX
@misc{bill-2024-sb353, title = {SB 353-FN (2024): relative to insurance coverage for autism spectrum disorder and Down syndrome.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2024/sb353}, note = {Accessed 24 Oct. 2026} }
SB 353-FN (2024)
relative to insurance coverage for autism spectrum disorder and Down syndrome.
- Status: Referred for interim study
- Term: 2023-2024
- House committee: Commerce and Consumer Affairs
- Senate committee: Health and Human Services
- Subject: Insurance
The Story
It was introduced on January 3, 2024 and referred to the Senate Health and Human Services committee. The committee held a public hearing on January 24, 2024. The committee voted unanimously, 5–0, to recommend that the Senate pass it, and the report was placed on the consent calendar. On February 8, 2024 the Senate voted to pass it on a voice vote and ordered it to a third reading. It crossed to the House on February 22, 2024 and was referred to the House Commerce and Consumer Affairs committee. The committee held a public hearing on April 23, 2024, with 62 people signed in online: 62 in support. The committee held a work session on May 7, 2024. The committee met in executive session on May 15, 2024 to vote on its recommendation. The committee voted unanimously, 18–0, to recommend that the House study it after the session ends, and the report was placed on the consent calendar. On May 23, 2024 the House voted to study it after the session ends on a voice vote. The committee held work sessions on September 12, 2024 and September 24, 2024. The committee met in executive session on October 17, 2024 to vote on its recommendation. The committee reported back on its interim study of the bill: “Not Recommended for Future Legislation”, by a vote of 16 to 0.
Sponsors
- Sen. David Watters (D - SD4) (prime sponsor)
- Sen. Donna Soucy (D - SD18)
- Sen. Rebecca Perkins Kwoka (D - SD21)
- Sen. Bill Gannon (R - SD23)
- Sen. Regina Birdsell (R - SD19)
- Sen. Lou D'Allesandro (D - SD20)
- Sen. Daniel Innis (R - SD7)
- Sen. Ruth Ward (R - SD8)
- Sen. Sharon Carson (R - SD14)
- Sen. Debra Altschiller (D - SD24)
- Sen. Shannon Chandley (D - SD11)
- Rep. Wayne MacDonald (R - Rock 16)
- Rep. David Nagel (D - Belk 6)
Hearings and Sessions
- January 24, 2024, 9:20 AM: hearing, Senate Health and Human Services, LOB 101
- April 23, 2024, 2:15 PM: public hearing, House Commerce and Consumer Affairs, LOB 302-304
- May 7, 2024, 10:00 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302-304
- May 15, 2024, 10:00 AM: executive session, House Commerce and Consumer Affairs, LOB 302-304
- September 12, 2024, 10:00 AM: full committee work session, House Commerce and Consumer Affairs, LOB 302-304
- September 24, 2024, 11:00 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302-304
- October 17, 2024, 10:00 AM: executive session, House Commerce and Consumer Affairs, LOB 302-304
Votes
- February 8, 2024, Senate: Ought to Pass — voice vote, passed
- May 23, 2024, House: Refer for Interim Study — voice vote, passed
The Docket
- January 3, 2024: To Be Introduced 01/03/2024 and Referred to Health and Human Services
- January 24, 2024: Hearing: 01/24/2024, Room 101, LOB, 09:20 am
- February 8, 2024: Committee Report: Ought to Pass, 02/08/2024; Vote 5-0; CC
- February 8, 2024: Ought to Pass : MA, VV; OT3rdg; 02/08/2024
- February 22, 2024: Introduced (in recess of) 02/22/2024 and referred to Commerce and Consumer Affairs
- April 23, 2024: Public Hearing: 04/23/2024 02:15 pm LOB 302-304
- May 7, 2024: Subcommittee Work Session: 05/07/2024 10:00 am LOB 302-304
- May 15, 2024: Executive Session: 05/15/2024 10:00 am LOB 302-304
- May 15, 2024: Committee Report: Refer for Interim Study 05/15/2024 (Vote 18-0; CC)
- May 23, 2024: Refer for Interim Study: MA VV 05/23/2024
- September 12, 2024: Full Committee Work Session: 09/12/2024 10:00 am LOB 302-304
- September 24, 2024: Subcommittee Work Session: 09/24/2024 11:00 am LOB 302-304
- October 17, 2024: Executive Session: 10/17/2024 10:00 am LOB 302-304
- October 31, 2024: Interim Study Report: Not Recommended for Future Legislation (Vote 16-0)